A Clinical Comparison of Marketed Lens Care Solutions With Avaira Lens Brand
Sponsor: CooperVision, Inc.
This NA trial investigates Corneal Staining and is currently completed. CooperVision, Inc. leads this study, which shows 11 recorded versions since 2010 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
May 2025 — Present [monthly]
Completed NA
-
Jan 2025 — May 2025 [monthly]
Completed NA
-
Sep 2024 — Jan 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
▶ Show 6 earlier versions
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
-
Aug 2020 — Jan 2021 [monthly]
Completed NA
Phase: PHASE4 → NA
-
Jun 2018 — Aug 2020 [monthly]
Completed PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE4
First recorded
Aug 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CooperVision, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .